New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Drugmaker AbbVie says these patients often undergo surgery and then are treated with chemotherapy. But they can become resistant to that chemotherapy and require another treatment option. In clinical trials, patients who received the antibody-drug conjugate had increased overall survival rates. Illustration by Julie Bang for Verywell Health Elahere reduced the risk of cancer progression by 35% compared to conventional chemotherapy. What Are Antibody-Drug Conjugates? Mostchemotherapy treatmentsare given systemically, meaning they impact the entire body....